Skip to content

Nuvation Bio NUVB Income Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$83.23M+98.8%$41.87M+219%$13.12M+171%$4.83M+56.7%$3.08M-46.0%
$35.05M+2.2%$34.3M+18.9%$28.85M+5.4%$27.36M+11.2%$24.6M-16.0%
$38.31M-5.0%$40.33M+7.9%$37.36M-2.9%$38.48M+8.7%$35.39M+35.4%
$79.35M-5.5%$83.92M+26.8%$66.21M+0.5%$65.85M+6.1%$62.09M-0.7%
$6.71M+0.5%$6.67M+2.1%$6.53M+1,452%$421K+680%$54K-39.3%
$1.52M$642K-86.0%$4.58M-20.6%$5.77M+28.3%
$5.4M+115%-$36.59M+34.4%-$55.79M+5.4%-$59.01M-10.8%-$53.24M-7.7%
$0$0$0$0$0
$5.4M+115%-$36.59M+34.4%-$55.79M+5.4%-$59.01M-10.8%-$53.24M-7.7%
6.5%+93.9pp-87.4%+338pp-425.2%+796pp-1,220.9%+505pp-1,726.2%-860pp
$4.42M+113%-$33.5M+40.1%-$55.9M+11.6%-$63.23M-7.7%-$58.69M-9.3%
5.3%+85.3pp-80%+346pp-426.1%+882pp-1,308.4%+595pp-1,903.2%-962pp
$3.88M+111%-$34.04M+39.7%-$56.43M+11.3%-$63.59M-7.8%-$59M-9.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Nuvation Bio's revenue?
Nuvation Bio (NUVB) generated $143.0M in revenue over the trailing twelve months, up 1205.5% year over year.
Is Nuvation Bio profitable?
Nuvation Bio is not currently profitable: it reported a net loss of $146.0M over the trailing twelve months, a -102.1% net margin.
What are Nuvation Bio's profit margins?
Gross margin is 54.3% and operating margin is -105.0%, with a -102.1% net margin.
What is Nuvation Bio's earnings per share?
Nuvation Bio's diluted EPS over the trailing twelve months is $-0.43.
Where does Nuvation Bio's income statement data come from?
Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.